Basic Information
Basic information for AL022068.1-231-51aa
Peptide Name AL022068.1-231-51aa
Genome Position chr6:19323540-19323692[-]
Species Human
Peptide Sequence MRQAYDSKCYTALSEKENLAFILLNPPSLSLGAWEFCESLPVAVTLICIWV
Peptide Length 51
Unique No (AL022068.1-201-51aa,AL022068.1-230-51aa,AL022068.1-232-51aa)
Grand Average of Hydropathicity 0.4941
Relative Molecular Mass 6636.48
Experimental Evidences no
lncRNA ID/Name ENSG00000228412;AL022068.1
Transcript ID/Name ENST00000653002;AL022068.1-231
Transcript Length 3407
Coding Ability 0.3745
DNA Sequence Corresponding to Peptide ATGAGGCAGGCTTATGACAGTAAATGCTACACTGCCCTCAGTGAAAAAGAGAATTTGGCATTCATTCTTCTGAACCCGCCATCCCTCAGCCTTGGCGCCTGGGAATTCTGCGAATCGTTGCCTGTGGCAGTGACACTGATTTGTATCTGGGTA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :